TITLE

Gabapentin Shows Promise in Treating Refractory Insomnia in Children

AUTHOR(S)
Robinson, Althea A.; Malow, Beth A.
PUB. DATE
December 2013
SOURCE
Journal of Child Neurology;Dec2013, Vol. 28 Issue 12, p1618
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Insomnia is prevalent in pediatrics, particularly in those with neurodevelopmental disorders. Gabapentin has shown promise in treating insomnia in adults. The purpose of our study was to review our experience with using gabapentin to treat insomnia in children. We identified 23 children, seen by the authors in our Pediatric Sleep Clinic from January 2009 to March 2012. The mean age was 7.2 years and 70% were male. The majority (87%) had been given diagnoses of neurodevelopmental or neuropsychiatric disorders. All parents received education in sleep behavioral interventions. The majority of children (70%) had both sleep-onset and sleep maintenance insomnia. The average starting dose of gabapentin was 5 mg/kg every bedtime and the maximal dose was 15 mg/kg every bedtime. At follow-up, improved sleep was noted in 78% of children. Adverse effects were noted in 6 children.
ACCESSION #
91947842

 

Related Articles

  • A 4½-Year-Old Girl With Frequent Nightime Awakenings. Rosen, Dennis // Clinical Pediatrics;Feb2010, Vol. 49 Issue 2, p186 

    The article presents a case study of a young girl who was taken to the Center for Pediatric Sleep Disorders at Children's Hospital in Boston, Massachusetts with the complaint of insomnia. As reported by the girl's parents, she awakes at least 1 to 3 times every night in order to urinate. The...

  • A systematic review of treatments for settling problems and night waking in young... Ramchandani, Paul; Wiggs, Luci; Stores, Gregory // BMJ: British Medical Journal (International Edition);01/22/2000, Vol. 320 Issue 7229, p209 

    Presents a study which assessed the efficacy of treatments for settling problems and night waking in young children. Characteristics of the participants; Methodology of the study; Results and conclusions.

  • Management. Zaiwalla, Zenobia // GP: General Practitioner;10/19/2007, p38 

    The article presents information on managing pediatric sleep disorders. Many pediatricians prescribe large doses of melatonin for insomnia in children with neurodevelopmental abnormalities and learning difficulties. However, the long-term safety of melatonin is not known and it should be avoided...

  • bedtime fading.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p253 

    An encyclopedia entry for "bedtime fading," which refers to a behavioral treatment for childhood insomnia, is presented.

  • Your Sleep Problems Solved! Sethi, Anita // Baby Talk;May2000, Vol. 65 Issue 4, p26 

    Presents pediatricians' answers to questions about baby's sleep. Suggestion before considering the sleep method created by Doctor Richard Ferber; Suggestion to parents whose newborn sleeps most of the day but is awake most of the night; Suggestion to encourage babies to take rest.

  • IL TRATTAMENTO COGNITIVO-COMPORTAMENTALE IN ETÀ EVOLUTIVA. Devoto, Alessandra // Cognitivismo Clinico;2016, Vol. 13 Issue 1, p68 

    This paper describes the cognitive-behavioural approach in the evaluation and treatment of childhood insomnia, considering in the current International Classifi cation of Sleep Disorders (ICSD-3). Sleep disorders must be placed in the framework of psychophysical conditions and child family...

  • Neurological disease models made clear.  // Nature Medicine;Sep2015, Vol. 21 Issue 9, p964 

    An introduction to the journal is presented in which the articles within the issue are discussed on topics including model systems for psychiatric disorders treatment, animal modeling of neuropsychiatric and neurodevelopmental disorders, and CNS (central nervous system) disease modeling.

  • Neurodevelopmental model of schizophrenia: update 2012. Rapoport, J L; Giedd, J N; Gogtay, N // Molecular Psychiatry;Dec2012, Vol. 17 Issue 12, p1228 

    The neurodevelopmental model of schizophrenia, which posits that the illness is the end state of abnormal neurodevelopmental processes that started years before the illness onset, is widely accepted, and has long been dominant for childhood-onset neuropsychiatric disorders. This selective review...

  • Exome sequencing of extended families with autism reveals genes shared across neurodevelopmental and neuropsychiatric disorders. Cukier, Holly N.; Dueker, Nicole D.; Slifer, Susan H.; Lee, Joycelyn M.; Whitehead, Patrice L.; Lalanne, Eminisha; Leyva, Natalia; Konidari, Ioanna; Gentry, Ryan C.; Hulme, William F.; Booven, Derek Van; Mayo, Vera; Hofmann, Natalia K.; Schmidt, Michael A.; Martin, Eden R.; Haines, Jonathan L.; Cuccaro, Michael L.; Gilbert, John R.; Pericak-Vance, Margaret A. // Molecular Autism; 

    Background Autism spectrum disorders (ASDs) comprise a range of neurodevelopmental conditions of varying severity, characterized by marked qualitative difficulties in social relatedness, communication, and behavior. Despite overwhelming evidence of high heritability, results from genetic studies...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics